No Data
No Data
Express News | Wells Fargo Maintains Overweight on Ventyx Biosciences, Lowers Price Target to $11
Ventyx Biosciences Is Maintained at Buy by Canaccord Genuity
Express News | Ventyx Biosciences Inc : Canaccord Genuity Cuts Target Price to $14 From $15
Ventyx Biosciences (VTYX) Receives a Buy From Oppenheimer
Ventyx Biosciences: A Buy Rating Backed by Promising Clinical Trials and Strong Financials
Ventyx Biosciences: A Cautious Hold Amid Intensifying Competition in Obesity Treatment Market
No Data
买跌不追涨 : Why was trading suspended? Will it plummet?
Trytosaveabit OP 买跌不追涨 : It was a T1 news halt as I posted! And this is the news! And yes i expect it to drop hard! NFA
买跌不追涨 Trytosaveabit OP : The news is bad, I just don't know where it will fall